Assistive Technology
Assistive Technology - Related Videos
08:34
Robot-assisted Partial Splenectomy
0 Views •
2026
This protocol describes a robot-assisted partial splenectomy for a benign splenic tumor. The robotic approach optimizes spleen preservation by enhancing surgical precision, minimizing blood loss, and improving postoperative outcomes. Key surgical steps include meticulous splenic hilum dissection, selective vascular ligation, intraoperative ultrasonography, and controlled parenchymal transection.
07:05
Microwave-Assisted Extraction of Phenolic Compounds and Antioxidants for Cosmetic Applications Using Polyol-Based Technology
0 Views •
Cited by 10 •
2024
This protocol details the utilization of a polyol-based microwave-assisted extraction method for extracting phenolic compounds and natural antioxidants, representing a practical and environmentally sustainable approach to the development of ready-to-use extracts.
01:26
Technological Change
0 Views •
2024
Total Factor Productivity (TFP) measures the efficiency with which inputs are transformed into outputs in production. It is the essence of economic growth, driven by technological advancement. Consider the agricultural sector, where production requires vast amounts of human labor and work animals. Today, modern farm machinery and agriculture technologies have revolutionized how we cultivate crops and produce food much more efficiently. TP = A*f(K, L) TFP is represented as a multiplier 'A' in...
01:31
Hybridoma Technology
0 Views •
2023
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy. Hybridoma Selection Commonly used fusion techniques — electroporation, polyethylene glycol...
07:06
Principles of Site-Specific Recombinase (SSR) Technology
0 Views •
Cited by 14 •
2008
The advent of site-specific recombinase (SSR) technology and the Cre/lox system has led to numerous advances in molecular biology, and has proven itself as a valuable tool for assessing gene function in transgenic animals. This interview discusses the mechanism of site specific recombination by Cyclization recombinase (Cre) and how the use of this enzyme has led to the development of conditional mutagenesis, which has significant advantages over traditional knock out strategies.
FAQs
In bioengineering, the functional loop links sensors, signal processing, control algorithms, and actuators. Sensors capture user intent or physiological signals; processing converts those inputs into usable information; algorithms determine an assistance response; and actuators produce movement or another functional output. This architecture allows powered prostheses, orthoses, and exoskeletons to deliver assistance based on individual input.
User intent and physiological signals are central variables because they determine how assistance is triggered or adjusted. Signal processing helps convert those measurements into information that a control algorithm can use, while actuator behavior determines the delivered assistance. The quality of this interaction affects usability and safety, making sensing, computation, and mechanical response important design targets in bioengineering.
Powered prostheses, orthoses, and exoskeletons represent different ways to address physical needs. Their designs can center on replacing, supporting, or augmenting physical function, respectively, although the specific role depends on the system. Comparing these platforms helps engineers match the device type, control strategy, and mechanical design to the user’s activity and rehabilitation goals.
Human-centered design keeps the person’s needs at the center of technical decisions. In assistive technology, engineers must connect biomechanics, materials science, electronics, and control considerations with practical requirements for usability and safety. This approach is especially important when devices support participation and independence, because technical capability alone does not determine whether a system improves quality of life.
A development approach in bioengineering should start from the physical, sensory, or cognitive need the system is intended to address. Engineers can then select an appropriate device or interface, integrate sensors and signal processing when user intent or physiological signals are relevant, and connect the resulting control strategy to an actuator. This need-centered workflow supports personalized rehabilitation and inclusive healthcare.
Assistive Technology is relevant across rehabilitation and inclusive healthcare because it can support independence, participation, and quality of life. Powered prostheses and orthoses address physical assistance, cochlear implants address sensory needs, and augmentative communication interfaces address communication-related needs. Together, these applications show how bioengineering adapts devices, software, and control systems to varied functional requirements.